New York, Jan 30, 2026, 3:10 PM EST — Regular session
- Shares of TTM Technologies climbed in afternoon trading following a supply agreement with Raytheon
- The company said the contract could be worth up to $200 million over three years
- The stock joins the S&P MidCap 400 on Friday, a move that could trigger index-driven buying.
Shares of TTM Technologies (TTMI.O) climbed $2.50, or roughly 2.6%, to $98.98 in Friday afternoon trading. The boost came after a Raytheon unit handed the company a multi-year deal linked to a U.S. air and missile defense radar system.
The deal is significant because it locks TTM further into the defense electronics supply chain, known for steadier volumes but strict delivery deadlines. It also provides investors with a clear number to debate—“potential value” differs from actual booked revenue.
Another factor driving the stock on Friday is mechanical: TTM is joining a larger index. This shift often triggers forced buying from funds tied to those benchmarks, which can skew trading activity near the close, particularly when volumes are elevated.
TTM and Raytheon, a division of RTX, have inked a deal to supply radio-frequency assemblies, electronic hardware, and printed circuit boards for Raytheon’s Lower Tier Air and Missile Defense Sensor (LTAMDS) program. The contract could be worth up to $200 million over three years. Raytheon VP Mike Mills said the multi-year agreement supports their accelerated delivery timeline and cuts costs. Catherine Gridley, TTM’s aerospace and defense chief, described the deal as a strong renewal of their long-term partnership.
S&P Dow Jones Indices announced that TTM will replace Civitas Resources in the S&P MidCap 400 before trading opens Friday. At the same time, Amneal Pharmaceuticals is set to take TTM’s spot in the S&P SmallCap 600.
The group showed varied moves. Jabil dropped roughly 2.7%, Sanmina slid close to 7%, while Plexus edged up around 1.5%. RTX shares saw minimal change.
Traders are eyeing whether the defense win shifts sentiment on 2026 demand and factory loading, or if it remains a headline that fades after the index rebalancing wraps up. The contract’s value is described as “potential,” allowing for timing adjustments based on program schedules and procurement.
The downside scenario is straightforward: defense programs falter, orders pile up, and enthusiasm for longer-duration contracts outpaces what the quarterly figures reveal. Index-driven buying may also unwind when these one-off flows dry up.
TTM will hold its fourth-quarter and full-year earnings call on Feb. 4. Investors will be tuning in for updates on LTAMDS progress, the state of aerospace and defense demand, and potential margin pressures related to capacity and delivery expansions.
Related articles: NYSE:RTX
